Landscape Capital Management’s Apexigen, Inc. Common Stock APGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-24,131
Closed -$243K 1073
2022
Q1
$243K Sell
24,131
-8,672
-26% -$87K 0.03% 515
2021
Q4
$328K Hold
32,803
0.05% 322
2021
Q3
$326K Buy
32,803
+11,816
+56% +$117K 0.05% 346
2021
Q2
$208K Buy
+20,987
New +$208K 0.03% 438

Other funds holding APGN

Landscape Capital Management's APGN Position: Q2 2022 in Review

Landscape Capital Management sold out of Apexigen, Inc. Common Stock (APGN) in Q2 2022, closing a stake of 24,131 shares — an estimated $243K sold.

Landscape Capital Management first reported a position in APGN in Q2 2021 and held it in 4 quarters. The position peaked at $328K in Q4 2021. 27 funds tracked by Wall St. Rank hold APGN as of Q2 2022.

  • Landscape Capital Management reported no remaining Apexigen, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Landscape Capital Management sold 24,131 Apexigen, Inc. Common Stock shares in Q2 2022, an estimated $243K.
  • Landscape Capital Management first reported a position in Apexigen, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Landscape Capital Management's Apexigen, Inc. Common Stock position peaked at $328K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q2 2022.

Based on Landscape Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.